Abstract
Embryonic stem cells and induced pluripotent stem (iPS) cells are characterized by their ability to self-renew and to generate differentiated cells of all three germ layers. This potential makes them an attractive source to address question of developmental and also for use in clinical regenerative medicine. Although the culture conditions to maintain pluripotency and reprogramming technologies have been established, the underlying molecular mechanisms are incompletely understood. Accumulating evidence indicates that the Wnt/β-catenin signaling pathway plays a pivotal role in the maintenance of pluripotency as well as in the process of somatic cell reprogramming. Reciprocally, Wnt/β-catenin signaling also plays a critical role in the lineage decision/commitment process. These dramatically different outcomes upon activation of the Wnt signaling cascade has fueled enormous controversy concerning the role of Wnt signaling in the maintenance of potency and induction of differentiation in stem cells. Here, we discuss and explore the divergent roles of the Wnt signaling pathways based on findings from our lab. Accumulated results from our lab indicate the usage of a critical switching mechanism that regulates the divergent Wnt/catenin transcriptional programs associated with either maintenance of potency or initiation of differentiation.
Similar content being viewed by others
Abbreviations
- APC:
-
Adenomatous polyposis coli
- BMP4:
-
Bone morphogenetic protein 4
- BRG1:
-
Brahma-related gene 1
- CK1:
-
Casein kinase 1
- Dvl:
-
Dishevelled
- ES:
-
Embryonic stem
- FGF4:
-
Fibroblast growth factor 4
- Fz:
-
Frizzled
- GSK3:
-
Glycogen synthase kinase 3
- ICM:
-
Inner cell mass
- iPS:
-
Induced pluripotent stem
- Klf4:
-
Kruppel-like factor 4
- LIF:
-
Leukemia inhibitory factor
- LRP:
-
Low-density lipoprotein receptor-related protein
- MEF:
-
Mouse embryonic fibroblast
- Oct4:
-
Octamer binding transcription factor-4
- PCP:
-
Planar-cell-polarity
- Sox 2:
-
Sex determining region Y-box 2
- Stat3:
-
Signal transducer and activator of transcription 3
- TERT:
-
Telomerase reverse transcriptase
- TGFβ:
-
Transforming growth factor-beta
References
Evans, M. J., & Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154–156.
Sekkai, D., Gruel, G., Herry, M., et al. (2005). Microarray analysis of LIF/Stat3 transcriptional targets in embryonic stem cells. Stem cells (Dayton, Ohio), 23, 1634–1642.
Cartwright, P., McLean, C., Sheppard, A., Rivett, D., Jones, K., & Dalton, S. (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development, 132, 885–896.
Ying, Q. L., Wray, J., Nichols, J., et al. (2008). The ground state of embryonic stem cell self-renewal. Nature, 453, 519–523.
Qi, X., Li, T. G., Hao, J., et al. (2004). BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proceedings of the National Academy of Sciences of the United States of America, 101, 6027–6032.
Ying, Q. L., Nichols, J., Chambers, I., & Smith, A. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell, 115, 281–292.
Xu, R. H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., & Thomson, J. A. (2005). Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods, 2, 185–190.
Schuldiner, M., Yanuka, O., Itskovitz-Eldor, J., Melton, D. A., & Benvenisty, N. (2000). Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 97, 11307–11312.
Watabe, T., & Miyazono, K. (2009). Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Research, 19, 103–115.
Kunath, T., Saba-El-Leil, M. K., Almousailleakh, M., Wray, J., Meloche, S., & Smith, A. (2007). FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development, 134, 2895–2902.
Tesar, P. J., Chenoweth, J. G., Brook, F. A., et al. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature, 448, 196–199.
Chou, Y. F., Chen, H. H., Eijpe, M., et al. (2008). The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell, 135, 449–461.
Brons, I. G., Smithers, L. E., Trotter, M. W., et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature, 448, 191–195.
Okita, K., & Yamanaka, S. (2006). Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Current Stem Cell Research & Therapy, 1, 103–111.
Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
Merrill, B. J. (2008). Develop-WNTs in somatic cell reprogramming. Cell Stem Cell, 3, 465–466.
Baker, N. E. (1987). Molecular cloning of sequences from wingless, a segment polarity gene in Drosophila: the spatial distribution of a transcript in embryos. The EMBO Journal, 6, 1765–1773.
Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D., & Nusse, R. (1987). The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell, 50, 649–657.
Miller JR. The Wnts. Genome Biol 2002;3:REVIEWS3001.
Hagen, T., & Vidal-Puig, A. (2002). Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45. Biochemical and Biophysical Research Communications, 294, 324–328.
Mao, J., Wang, J., Liu, B., et al. (2001). Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Molecular Cell, 7, 801–809.
Liu, X., Rubin, J. S., & Kimmel, A. R. (2005). Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Current Biology, 15, 1989–1997.
Yokoya, F., Imamoto, N., Tachibana, T., & Yoneda, Y. (1999). beta-catenin can be transported into the nucleus in a Ran-unassisted manner. Molecular Biology of the Cell, 10, 1119–1131.
Gan, X. Q., Wang, J. Y., Xi, Y., Wu, Z. L., Li, Y. P., & Li, L. (2008). Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction. The Journal of Cell Biology, 180, 1087–1100.
Zeng, X., Tamai, K., Doble, B., et al. (2005). A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature, 438, 873–877.
Tada, M., Concha, M. L., & Heisenberg, C. P. (2002). Non-canonical Wnt signalling and regulation of gastrulation movements. Seminars in Cell & Developmental Biology, 13, 251–260.
Kuhl, M., Sheldahl, L. C., Park, M., Miller, J. R., & Moon, R. T. (2000). The Wnt/Ca2+ pathway: A new vertebrate Wnt signaling pathway takes shape. Trends in Genetics, 16, 279–283.
He, X., Saint-Jeannet, J. P., Wang, Y., Nathans, J., Dawid, I., & Varmus, H. (1997). A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science, 275, 1652–1654.
Ishitani, T., Kishida, S., Hyodo-Miura, J., et al. (2003). The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Molecular and Cellular Biology, 23, 131–139.
Sonderegger, S., Pollheimer, J., & Knofler, M. (2010). Wnt signalling in implantation, decidualisation and placental differentiation–review. Placenta, 31, 839–847.
De Vries, W. N., Evsikov, A. V., Haac, B. E., et al. (2004). Maternal beta-catenin and E-cadherin in mouse development. Development, 131, 4435–4445.
Haegel, H., Larue, L., Ohsugi, M., Fedorov, L., Herrenknecht, K., & Kemler, R. (1995). Lack of beta-catenin affects mouse development at gastrulation. Development, 121, 3529–3537.
Xie, H., Tranguch, S., Jia, X., et al. (2008). Inactivation of nuclear Wnt-beta-catenin signaling limits blastocyst competency for implantation. Development, 135, 717–727.
Chen, Q., Zhang, Y., Lu, J., et al. (2009). Embryo-uterine cross-talk during implantation: The role of Wnt signaling. Molecular Human Reproduction, 15, 215–221.
Slusarski, D. C., Corces, V. G., & Moon, R. T. (1997). Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature, 390, 410–413.
Kuhl, M., Sheldahl, L. C., Malbon, C. C., & Moon, R. T. (2000). Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. The Journal of Biological Chemistry, 275, 12701–12711.
Sheldahl, L. C., Park, M., Malbon, C. C., & Moon, R. T. (1999). Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Current Biology, 9, 695–698.
Slusarski, D. C., & Pelegri, F. (2007). Calcium signaling in vertebrate embryonic patterning and morphogenesis. Developmental Biology, 307, 1–13.
Mohamed, O. A., Jonnaert, M., Labelle-Dumais, C., Kuroda, K., Clarke, H. J., & Dufort, D. (2005). Uterine Wnt/beta-catenin signaling is required for implantation. Proceedings of the National Academy of Sciences of the United States of America, 102, 8579–8584.
Ishikawa, T., Tamai, Y., Zorn, A. M., et al. (2001). Mouse Wnt receptor gene Fzd5 is essential for yolk sac and placental angiogenesis. Development, 128, 25–33.
Galceran, J., Farinas, I., Depew, M. J., Clevers, H., & Grosschedl, R. (1999). Wnt3a-/- like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes & Development, 13, 709–717.
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999). Requirement for Wnt3 in vertebrate axis formation. Nature Genetics, 22, 361–365.
Takada, S., Stark, K. L., Shea, M. J., Vassileva, G., McMahon, J. A., & McMahon, A. P. (1994). Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes & Development, 8, 174–189.
Wurst, W., & Bally-Cuif, L. (2001). Neural plate patterning: upstream and downstream of the isthmic organizer. Nature Reviews. Neuroscience, 2, 99–108.
Rowitch, D. H., & McMahon, A. P. (1995). Pax-2 expression in the murine neural plate precedes and encompasses the expression domains of Wnt-1 and En-1. Mechanisms of Development, 52, 3–8.
Reya, T., & Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature, 434, 843–850.
Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell, 127, 469–480.
Mimeault, M., & Batra, S. K. (2006). Concise review: Recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem cells (Dayton, Ohio), 24, 2319–2345.
Reya, T., Duncan, A. W., Ailles, L., et al. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423, 409–414.
Kalani, M. Y., Cheshier, S. H., Cord, B. J., et al. (2008). Wnt-mediated self-renewal of neural stem/progenitor cells. Proceedings of the National Academy of Sciences of the United States of America, 105, 16970–16975.
Zeng, Y. A., & Nusse, R. (2010). Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell, 6, 568–577.
He, S., Pant, D., Schiffmacher, A., Meece, A., & Keefer, C. L. (2008). Lymphoid enhancer factor 1-mediated Wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells. Stem cells (Dayton, Ohio), 26, 842–849.
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Natural Medicines, 10, 55–63.
Anton, R., Kestler, H. A., & Kuhl, M. (2007). Beta-catenin signaling contributes to stemness and regulates early differentiation in murine embryonic stem cells. FEBS Letters, 581, 5247–5254.
Aubert, J., Dunstan, H., Chambers, I., & Smith, A. (2002). Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nature Biotechnology, 20, 1240–1245.
Singla, D. K., Schneider, D. J., LeWinter, M. M., & Sobel, B. E. (2006). wnt3a but not wnt11 supports self-renewal of embryonic stem cells. Biochemical and Biophysical Research Communications, 345, 789–795.
Hao, J., Li, T. G., Qi, X., Zhao, D. F., & Zhao, G. Q. (2006). WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Developmental Biology, 290, 81–91.
Kiyonari, H., Kaneko, M., Abe, S., & Aizawa, S. (2010). Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline-competent embryonic stem cells of C57BL/6 N mouse strain with high efficiency and stability. Genesis, 48, 317–327.
Sato, H., Amagai, K., Shimizukawa, R., & Tamai, Y. (2009). Stable generation of serum- and feeder-free embryonic stem cell-derived mice with full germline-competency by using a GSK3 specific inhibitor. Genesis, 47, 414–422.
Kielman, M. F., Rindapaa, M., Gaspar, C., et al. (2002). Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nature Genetics, 32, 594–605.
Dravid, G., Ye, Z., Hammond, H., et al. (2005). Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem cells (Dayton, Ohio), 23, 1489–1501.
Ogawa, K., Nishinakamura, R., Iwamatsu, Y., Shimosato, D., & Niwa, H. (2006). Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochemical and Biophysical Research Communications, 343, 159–166.
Takao, Y., Yokota, T., & Koide, H. (2007). Beta-catenin up-regulates Nanog expression through interaction with Oct-3/4 in embryonic stem cells. Biochemical and Biophysical Research Communications, 353, 699–705.
Pereira, L., Yi, F., & Merrill, B. J. (2006). Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal. Molecular and Cellular Biology, 26, 7479–7491.
Le, N. H., Franken, P., & Fodde, R. (2008). Tumour-stroma interactions in colorectal cancer: converging on beta-catenin activation and cancer stemness. British Journal of Cancer, 98, 1886–1893.
Kim, Y. M., Ma, H., Oehler, V. G., et al. (2011). The gamma catenin/CBP complex maintains survivin transcription in beta-catenin deficient/depleted cancer cells. Current Cancer Drug Targets, 11, 213–225.
Cole, M. F., Johnstone, S. E., Newman, J. J., Kagey, M. H., & Young, R. A. (2008). Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes & Development, 22, 746–755.
Kelly, K. F., Ng, D. Y., Jayakumaran, G., Wood, G. A., Koide, H., & Doble, B. W. (2011). beta-Catenin Enhances Oct-4 Activity and Reinforces Pluripotency through a TCF-Independent Mechanism. Cell Stem Cell, 8, 214–227.
Hecht, A., Vleminckx, K., Stemmler, M. P., van Roy, F., & Kemler, R. (2000). The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. The EMBO Journal, 19, 1839–1850.
Takemaru, K. I., & Moon, R. T. (2000). The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression. The Journal of Cell Biology, 149, 249–254.
Yao, T. P., Oh, S. P., Fuchs, M., et al. (1998). Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell, 93, 361–372.
Kawasaki, H., Taira, K., Yokoyama, K. K. (1999). Functional analysis of the transcriptional coactivators p300 and CBP using ribozyme. Nucleic Acids Symp Ser 263–264.
Roth, J. F., Shikama, N., Henzen, C., et al. (2003). Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5. The EMBO Journal, 22, 5186–5196.
Miyabayashi, T., Teo, J. L., Yamamoto, M., McMillan, M., Nguyen, C., & Kahn, M. (2007). Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proceedings of the National Academy of Sciences of the United States of America, 104, 5668–5673.
Wagner, R. T., Xu, X., Yi, F., Merrill, B. J., & Cooney, A. J. (2010). Canonical Wnt/beta-catenin regulation of liver receptor homolog-1 mediates pluripotency gene expression. Stem cells (Dayton, Ohio), 28, 1794–1804.
Chew, J. L., Loh, Y. H., Zhang, W., et al. (2005). Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Molecular and Cellular Biology, 25, 6031–6046.
Cai, L., Ye, Z., Zhou, B. Y., Mali, P., Zhou, C., & Cheng, L. (2007). Promoting human embryonic stem cell renewal or differentiation by modulating Wnt signal and culture conditions. Cell Research, 17, 62–72.
Ding, V. M., Ling, L., Natarajan, S., Yap, M. G., Cool, S. M., & Choo, A. B. (2010). FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signaling. Journal of Cellular Physiology, 225, 417–428.
Paling, N. R., Wheadon, H., Bone, H. K., & Welham, M. J. (2004). Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. The Journal of Biological Chemistry, 279, 48063–48070.
Marson, A., Foreman, R., Chevalier, B., et al. (2008). Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell, 3, 132–135.
Lluis, F., Pedone, E., Pepe, S., & Cosma, M. P. (2008). Periodic activation of Wnt/beta-catenin signaling enhances somatic cell reprogramming mediated by cell fusion. Cell Stem Cell, 3, 493–507.
Li, W., Zhou, H., Abujarour, R., et al. (2009). Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem cells (Dayton, Ohio), 27, 2992–3000.
Lluis, F., Pedone, E., Pepe, S., & Cosma, M. P. (2010). The Wnt/beta-catenin signaling pathway tips the balance between apoptosis and reprograming of cell fusion hybrids. Stem cells (Dayton, Ohio), 28, 1940–1949.
Ma, H., Nguyen, C., Lee, K. S., & Kahn, M. (2005). Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene, 24, 3619–3631.
Kawamura, T., Suzuki, J., Wang, Y. V., et al. (2009). Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature, 460, 1140–1144.
Barker, N., Hurlstone, A., Musisi, H., Miles, A., Bienz, M., & Clevers, H. (2001). The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. The EMBO Journal, 20, 4935–4943.
Park, J. I., Venteicher, A. S., Hong, J. Y., et al. (2009). Telomerase modulates Wnt signalling by association with target gene chromatin. Nature, 460, 66–72.
Randazzo, F. M., Khavari, P., Crabtree, G., Tamkun, J., & Rossant, J. (1994). brg1: A putative murine homologue of the Drosophila brahma gene, a homeotic gene regulator. Developmental Biology, 161, 229–242.
Shi, Y., Do, J. T., Desponts, C., Hahm, H. S., Scholer, H. R., & Ding, S. (2008). A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell, 2, 525–528.
Matsumoto, S., Banine, F., Struve, J., et al. (2006). Brg1 is required for murine neural stem cell maintenance and gliogenesis. Developmental Biology, 289, 372–383.
Bultman, S., Gebuhr, T., Yee, D., et al. (2000). A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Molecular Cell, 6, 1287–1295.
Conflict of Interest
The authors have received no payment for the preparation of this manuscript and state no financial and non-financial conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miki, T., Yasuda, Sy. & Kahn, M. Wnt/β-catenin Signaling in Embryonic Stem Cell Self-renewal and Somatic Cell Reprogramming. Stem Cell Rev and Rep 7, 836–846 (2011). https://doi.org/10.1007/s12015-011-9275-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-011-9275-1